Cadrenal Therapeutics Inc (CVKD)
0.4905
+0.03
(+5.48%)
USD |
NASDAQ |
May 03, 16:00
0.4905
0.00 (0.00%)
After-Hours: 06:37
Cadrenal Therapeutics Free Cash Flow (Quarterly): -0.6944M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.6944M |
| September 30, 2023 | -0.6278M |
| June 30, 2023 | -0.7986M |
| March 31, 2023 | -1.413M |
| Date | Value |
|---|---|
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | -0.0437M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-1.413M
Minimum
Mar 2023
-0.0437M
Maximum
Mar 2022
-0.7155M
Average
-0.6944M
Median
Dec 2023
Free Cash Flow (Quarterly) Benchmarks
| Tenax Therapeutics Inc | -1.174M |
| Syra Health Corp | -1.757M |
| Minerva Neurosciences Inc | -5.991M |
| Adverum Biotechnologies Inc | -21.52M |
| Genprex Inc | -4.974M |